Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1489, Issue 1, 1999, Pages 107-116

  Krieg, Arthur M ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c CpG ImmunoPharmaceuticals   (United States)

Author keywords

B cell; Immunomodulator; Lymphocyte activation; Monocyte; Natural killer cell

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BACTERIAL DNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

B LYMPHOCYTE; HUMAN; IMMUNITY; IMMUNOSTIMULATION; IMMUNOTOXICITY; LYMPHOCYTE ACTIVATION; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CPG ISLANDS; DENDRITIC CELLS; DNA, BACTERIAL; HUMANS; LISTERIA INFECTIONS; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MALARIA; MICE; MONOCYTES; OLIGODEOXYRIBONUCLEOTIDES; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; T-LYMPHOCYTES; VACCINES, DNA;

VERTEBRATA;

EID: 0032720361     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(99)00147-5     Document Type: Review

References (75)

1. Bird A.P. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:1987;342-347.
2. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., Furutani Y., Yano O., Kataoka T., Sudo T., Makiguchi N., Suganuma T. Antitumor activity of deoxyribonucleic acid fraction from mycobacterium bovis GCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72:1984;955-962.
3. Tokunaga T., Yamamoto S., Namba K. A synthetic single-stranded DNA, poly(dG,dC), induces interferon-α/β and -γ, augments natural killer activity, and suppresses tumor growth. Jpn. J. Cancer Res. 79:1988;682-686.
4. Kuramoto E., Yano O., Kimura Y., Baba M., Makino T., Yamamoto S., Yamamoto T., Kataoka T., Tokunaga T. Oligonucleotide sequences required for natural killer cell activation. Jpn. J. Cancer Res. 83:1992;1128-1131.
5. Messina J.P., Gilkeson G.S., Pisetsky D.S. The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. Cell. Immunol. 147:1993;148-157.
6. Park S.J., Kim W.H., Han K.H., Chon C.Y., Hahm K.B., Moon Y.M., Kang J.K., Park I.S., Youn J.K. Adjuvant effect of polyadenylic/polyuridylic acid on antibody production of recombinant hepatitis B surface antigen in mice. Int. J. Immunopharmacol. 17:1995;513-516.
7. Hahm K.B., Han K.Y., Kim W.H., Yim D.S., Chon C.Y., Moon Y.M., Kang J.K., Park I.S., Youn J.K., Deschamps de Paillette E. Efficacy of polyadenylic·polyuridylic acid in the treatment of chronic active hepatitis B. Int. J. Immunopharmacol. 16:1994;217-225.
8. Khan A.L., Richardson S., Drew J., Larsen F., Campbell M., Heys S.D., Ah-See A.K., Eremin O. Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery. 118:1995;531-538.
9. Tanaka T., Chu C.C., Paul W.E. An antisense oligonucleotide complementary to a sequence in Iγ2b increases γ2b germline transcripts, stimulates B cell DNA synthesis, and inhibits immunoglobulin secretion. J. Exp. Med. 175:1992;597-607.
10. Branda R.F., Moore A.L., Mathews L., McCormack J.J., Zon G. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1. Biochem. Pharmacol. 45:1993;2037-2043.
11. Liang H., Nishioka Y., Reich C.F., Pisetsky D.S., Lipsky P.E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98:1996;1119-1129.
12. McIntyre K.W., Lombard-Gillooly K., Perez J.R., Kunsch C., Sarmiento U.M., Larigan J.D., Landreth K.T., Narayanan R. A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-κB p65 causes sequence-specific immune stimulation. Antisense Res. Dev. 3:1993;309-322.
13. Pisetsky D.S., Reich C.F. Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. Life Sci. 54:1993;101-107.
14. Krieg A.K., Yi A.-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G., Klinman D. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
15. Krieg A.M., Gause W.C., Gourley M.F., Steinberg A.D. A role for endogenous retroviral sequences in the regulation of lymphocyte activation. J. Immunol. 143:1989;2448-2451.
16. Hatzfeld J., Li M.-L., Brown E.L., Sookdeo H., Levesque J.-P., O'Toole T., Gurney C., Clark S.C., Hatzfeld A. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor α1 or Rb oligonucleotides. J. Exp. Med. 174:1991;925-929.
17. Mojcik C., Gourley M.F., Klinman D.M., Krieg A.M., Gmelig-Meyling F., Steinberg A.D. Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner. Clin. Immunol. Immunopathol. 67:1993;130-136.
18. Krieg A., Tonkinson J., Matson S., Zhao Q., Saxon M., Zhang L.-M., Bhanja U., Yakubov L., Stein C.A. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc. Natl. Acad. Sci. USA. 90:1993;1048-1052.
19. Koike M., Ishino K., Ikuta T., Ho N.-H., Kuroki T. Growth enhancement of normal human keratinocytes by the antisense oligonucleotide of retinoblastoma susceptibility gene. J. Biochem. 116:1995;991-994.
20. Fischer G., Kent S.C., Joseph L., Green D.R., Scott D.W. Lymphoma models for B cell activation and tolerance. X. Anti-u-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J. Exp. Med. 179:1994;221-228.
21. Azad R.F., Driver V.B., Tanaka K., Crooke R.M., Anderson K.P. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob. Agents Chemother. 37:1993;1945-1954.
22. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147:1991;1759-1764.
23. Shpaer E.G., Mullins J.I. Selection against CpG dinucleotides in lentiviral genes: a possible role of methylation in regulation of viral expression. Nucleic Acids Res. 18:1990;5793-5797.
24. Karlin S., Doerfler W., Cardon L.R. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J. Virol. 68:1994;2889-2897.
25. Karlin S., Ladunga I., Blaisdell B.E. Heterogeneity of genomes: measures and values. Proc. Natl. Acad. Sci. USA. 91:1994;12837-12841.
26. Sun S., Beard C., Jaenisch R., Jones P., Sprent J. Mitogenicity of DNA from different organisms for murine B cells. J. Immunol. 159:1997;3119-3125.
27. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Zhang L., Yang L., Yi A.K., Short D., Davis H. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA. 95:1998;12631-12636.
28. Yi A.-K., Klinman D.M., Martin T.L., Matson S., Krieg A.M. Rapid immune activation by CpG motifs in bacterial DNA: systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157:1996;5394-5402.
29. Klinman D., Yi A.-K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN. Proc. Natl. Acad. Sci. USA. 93:1996;2879-2883.
30. Redford T.W., Yi A.-K., Ward C.T., Krieg A.M. Cyclosporine A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J. Immunol. 161:1998;3930-3935.
31. Stacey K.J., Sweet M.J., Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:1996;2116-2122.
32. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84:1997;185-193.
33. Sparwasser T., Miethe T., Lipford G., Erdmann A., Hacker H., Heeg K., Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-α-mediated shock. Eur. J. Immunol. 27:1997;1671-1679.
34. Halpern M.D., Kurlander R.J., Pisetsky D.S. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α Cell. Immunol. 167:1996;72-78.
35. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157:1996;1840-1845.
36. Cowdery J.S., Chace J.H., Yi A.-K., Krieg A.M. Bacterial DNA induces NK cells to produce interferon-γ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156:1996;4570-4575.
37. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161:1998;3042-3049.
38. Sparwasser T., Koch E.-S., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J., Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:1998;2045-2054.
39. S. Bendigs, U. Salzer, G.B. Lipford, H. Wagner, K. Heeg, CpG-oligodeoxynucleotides costimulate primary T cells in the absence of APC, Eur. J. Immunol. (1998) in press.
40. Yi A.-K., Chang M., Peckham D.W., Krieg A.M., Ashman R.F. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol. 160:1998;5898-5906.
41. 3H-thymidine incorporation by 'control' oligonucleotides. Antisense Res. Dev. 2:1992;325-330.
42. Zhao Q., Matson S., Herrara C.J., Fisher E., Yu H., Waggoner A., Krieg A.M. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3:1993;53-66.
43. Krieg A.M., Matson S., Herrera C., Fisher E. Oligodeoxynucleotide modifications determine the magnitude of immune stimulation by CpG motifs. Antisense Res. Dev. 6:1996;133-139.
44. Zhao Q., Temsamani J., Iadarola P.L., Jiang Z., Agrawal S. Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol. 51:1996;173-182.
45. Jones T.R., Obaldia N. III, Gramzinski R.A., Charoenvit Y., Kolodny N., Davis H.L., Krieg A.M., Hoffman S.L. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine. 17:1999;3065-3071.
46. Bennett R.M., Gabor G.T., Merritt M.M. DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA. J. Clin. Invest. 76:1985;2182-2190.
47. Yakubov L.A., Deeva E.A., Zarytova V.F., Ivanova E.M., Ryte A.S., Yurchenko L.V., Vlassov V.V. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors. Proc. Natl. Acad. Sci. USA. 86:1989;6454-6458.
48. Loke S.L., Stein C.A., Zhang X.H., Mori K., Nakanishi M., Subasinghe C., Cohen J.S., Neckers L.M. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA. 86:1989;3474-3478.
49. Yamamoto T., Yamamoto S., Kataoka T., Tokunaga T. Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity. Microbiol. Immunol. 38:1994;831-836.
50. MacFarlane D.E., Manzel L. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160:1998;1122-1131.
51. Hacker H., Mischak H., Miethke T., Liptay S., Schmid R., Sparwasser T., Heeg K., Lipford G.B., Wagner H. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17:1998;6230-6240.
52. Krieg A.M., Gmelig-Meyling F., Gourley M.F., Kisch W.J., Chrisey L.A., Steinberg A.D. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res. Dev. 1:1991;161-171.
53. Zhao Q., Song X., Waldschmidt T., Fisher E., Krieg A.M. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood. 88:1996;1788-1795.
54. Hartmann G., Krug A., Bidlingmaier M., Hacker U., Eigler A., Albrecht R., Strasburger C.J., Endres S. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes. J. Pharmacol. Exp. Ther. 285:1998;920-928.
55. Kronenwett R., Steidl U., Kirsch M., Sczakiel G., Haas R. Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset. Blood. 191:1998;852-862.
56. Tonkinson J.L., Stein C.A. Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 22:1994;4268-4275.
57. Yi A.-K., Tuetken R., Redford T., Kirsch J., Krieg A.M. CpG motifs in bacterial DNA activates leukocytes through the pH-dependent generation of reactive oxygen species. J. Immunol. 160:1998;4755-4761.
58. Yi A.-K., Krieg A.M. Rapid induction of mitogen activated protein kinases by immune stimulatory CpG DNA. J. Immunol. 161:1998;4493-4497.
59. Yi A.-K., Hornbeck P., Lafrenz D.E., Krieg A.M. CpG DNA rescue of murine B lymphoma cells from anti-IgM induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-XL. J. Immunol. 157:1996;4918-4925.
60. Sparwasser T., Miethke T., Lipford G., Borschert K., Hacker H., Heet K., Wagner H. Bacterial DNA causes septic shock. Nature. 386:1997;336-337.
61. Krieg A.M., Love-Homan L., Yi A.-K., Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:1998;2428-2434.
62. R.A. Gramzinski, M. Sedegah, D. Doolan, A.M. Krieg, H.L. Davis, S.L. Hoffman, IL12- and IFN-γ-dependent protection of mice against malaria conferred by CpG DNA, Mol. Med. (1999) in press.
63. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.-D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:1997;849-854.
64. Lipford G.B., Bauer M., Blank C., Reiter R., Wagner H., Heeg K. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur. J. Immunol. 27:1997;2340-2344.
65. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on Th1 immunity. J. Exp. Med. 186:1997;1623-1631.
66. Davis H.L., Weeranta R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent adjuvant in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:1998;870-876.
67. Weiner G.J., Liu H.-M., Wooldridge J.E., Dahle C.E., Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA. 94:1997;10833.
68. Moldoveanu Z., Love-Homan L., Huang W.Q., Krieg A.M. CpG DNA, a novel adjuvant for systemic and mucosal immunization with influenza virus. Vaccine. 16:1998;1216-1224.
69. Kline J.N., Waldschmidt T.J., Businga T.R., Lemish J.E., Weinstock J.V., Thorne P.S., Krieg A.M. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:1998;2555-2559.
70. Sun S., Kishimoto H., Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J. Exp. Med. 187:1998;1145-1150.
71. Boggs R.T., McGraw K., Condon T., Flournoy S., Villiet P., Bennett C.F., Monia B.P. Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev. 7:1997;461-471.
72. Crooke R.M., Crooke S.T., Graham M.J., Cooke M.E. Effect of antisense oligonucleotides on cytokine release from human keratinocytes in an in vitro model of skin. Toxicol. Appl. Pharmacol. 140:1996;85-93.
73. Kimura Y., Sonehara K., Kuramoto E., Makino T., Yamamoto S., Yamamoto T., Kataoka T., Tokunaga T. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J. Biochem. 116:1994;991-994.
74. Halpern H.D., Pisetsky D.S. In vitro inhibition of murine IFN-γ production by phosphorothioate deoxyguanosine oligomers. Immunopharmacology. 29:1995;47-52.
75. Pisetsky D.S., Reich C. Stimulation of in vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotides. Mol. Biol. Rep. 18:1993;217-221.